维普期刊资源整合服务平台（V6.5）

41篇 您的检索式：作者名="MEGO M"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancer显示文摘	Mego M Zuo Z Gao H	2014	Thromb Haemost2014，113，2：	1
2	Effect of mycotoxins on uptakeand degradation ofalbumin in mouse liver and kidneylysosomes显示文摘	Farb R M Mego J L Hayes A W	1976	Journal of Toxicology and Environmental Health1976，1，6：	1
3	Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer:The effect of neoadjuvant therapy显示文摘	Mego M Mani SA Lee BN	2012	Int J Cancer2012，130，4：	1
4	Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer 显示文摘	Cierna Z Mego M Janega P	2014	BMC Cancer2014，14，：	1
5	Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancer显示文摘	Mego M Zuo Z Gao H	2015	Thromb Haemost2015，113，2：	1
6	Molecular mechanisms of metastasis in breast cancer-clinical applications 显示文摘	Mego M Mani S A CristofaniUi M	2010	Nat Rev Clin Oncol2010，7，12：	1
7	Percutaneous implantation of a para- chute device for treatment of ischemic he'art failure 显示文摘	Cilingiroglu M Rollefson WA Mego D	2013	Cardiovasc Revasc Med2013，14，4：	1
8	Molecular mechanisms of metastasis in breast cancer- clinical applications显示文摘	Mego M Mani SA Cristofanilli M	2010	Nat Rev Clin Oncol2010，7，12：	1
9	Characterization of metastatic breast cancer patientswith nondetectable circulating tumor cells显示文摘	MEGO M DE GIORGI U DAWOOD S		Int JCancer0，129，2：	1
10	Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer显示文摘	De Giorgi U Mego M Scarpi E	2012	Clin Breast Cancer2012，12，4：	1
11	18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer显示文摘	De Giorgi U Mego M Rohren EM		0，，08：	1
12	Molecular mechanisms of metas- tasis in breast cancer-clinical applications显示文摘	Mego M Mani SA Cristofanilli M	2010	Nat Rev Clin Oncol2010，7，12：	1
13	Telomerase inhibitors in anticancer therapy: gossypol as a potential telomerase inhibitor 显示文摘	Mego M	2002	Bratisl Lek Listy2002，103，10：	1
14	Circulating tumor cells (CTCs) and epithelial mesenchymal transition (EMT) in breast cancer: de- scribing the heterogeneity of microscopic disease 显示文摘	Mego M Mani C Li C	2009	Cancer Res2009，69，3：	1
15	Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer;The effect of neoadjuvant therapy显示文摘	MEGO M MANI S A LEE B N	2012	Int J Cancer2012，130，4：	1
16	Increased cardiotoxicity of sorafenibin in sunitinib-pretreated patients with metastatic renal cell carcinoma显示文摘	Mego M Reckova M Obertova J	2007	Ann Oneol2007，18，11：	1
17	Telomerase inhibitors in anticancer therapy : gossypol as a potential telomerase inhibitor显示文摘	Mego M	2002	Bratisl Lek Listy2002，103，10：	1
18	Molecular mechanisms of metastasis in breast cancer--clinical applications显示文摘	Mego M Mani S A Cristofanilli M	2010	Nat Rev Clin Oncol2010，7，12：	1
19	Molecular mechanisms of me- tastasis in breast cancer-clinical applications 显示文摘	Mego M Mani S A Cristofanilli M	2010	Nat Rev Clin Onco12010，7，12：	1
20	Telomerase inhibitors in anticancer therpy:gpssy-pol as a potential telomerase inhibitor显示文摘	Mego M	2002	Bratisl Lek Listy2002，103，10：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示